Accessibility Menu
 

Anbio Biotechnology

(NASDAQ) NNNN

Current Price$29.04
Market Cap$1.28B
Since IPO (2025)+420%
5 YearN/A
1 Year+363%
1 Month+13%

Anbio Biotechnology Financials at a Glance

Market Cap

$1.28B

Revenue (TTM)

$18.60M

Net Income (TTM)

$9.75M

EPS (TTM)

$0.16

P/E Ratio

178.38

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$29.04

Volume

833

Open

$31.00

Previous Close

$29.04

Daily Range

$29.03 - $32.60

52-Week Range

$6.34 - $55.65

NNNN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anbio Biotechnology

Industry

Biotechnology

Employees

27

CEO

Michael Lau, PhD, MBA

Headquarters

Frankfurt am Main, 60437, DE

NNNN Financials

Key Financial Metrics (TTM)

Gross Margin

87%

Operating Margin

66%

Net Income Margin

74%

Return on Equity

27%

Return on Capital

21%

Return on Assets

24%

Earnings Yield

0.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.28B

Shares Outstanding

43.89M

Volume

833

Avg. Volume

41.51K

Financials (TTM)

Gross Profit

$7.54M

Operating Income

$5.77M

EBITDA

$5.77M

Operating Cash Flow

$6.74M

Capital Expenditure

$0.00

Free Cash Flow

$6.74M

Cash & ST Invst.

$11.90M

Total Debt

$0.00

Anbio Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.74M

+19.9%

Gross Profit

$3.86M

+128.2%

Gross Margin

81.49%

N/A

Market Cap

$1.28B

N/A

Market Cap/Employee

$47.47M

N/A

Employees

27

N/A

Net Income

$3.04M

+283.2%

EBITDA

$2.80M

+251.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$11.90M

+22.8%

Accounts Receivable

$3.66M

+94.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

23.76%

N/A

Return on Invested Capital

21.48%

N/A

Free Cash Flow

$1.60M

N/A

Operating Cash Flow

$1.60M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KALVKalVista Pharmaceuticals, Inc.
$26.71+0.19%
AVNSAvanos Medical, Inc.
$24.70+0.16%
CMPSCOMPASS Pathways plc
$9.32-2.10%
TALKTalkspace, Inc.
$5.20+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
DGXXDigi Power X
$5.11+0.29%
NOKNokia
$13.42+0.02%
CCLCarnival Corp.
$25.77+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.81+0.02%

Questions About NNNN

What is the current price of Anbio Biotechnology?

Anbio Biotechnology is trading at $29.04 per share.

What is the 52-week range for Anbio Biotechnology?

Over the past 52 weeks, Anbio Biotechnology has traded between $6.34 and $55.65.

How much debt does Anbio Biotechnology have?

As of the most recent reporting period, Anbio Biotechnology reported total debt of N/A.

How much cash does Anbio Biotechnology have on hand?

Anbio Biotechnology reported $9.12M in cash and cash equivalents in its most recent financial results.

What is Anbio Biotechnology’s dividend yield?

Anbio Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.